Dr. Fishbane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Community Drive
Manhasset, NY 11030Phone+1 516-465-8200Fax+1 516-465-8202- Is this information wrong?
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Nephrology, 1991 - 1993
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1989 - 1991
- Icahn School of Medicine at Mount Sinai (Beth Israel)Internship, Internal Medicine, 1988 - 1989
- Albert Einstein College of MedicineClass of 1988
Certifications & Licensure
- NY State Medical License 1990 - 2025
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease Start of enrollment: 2006 Jul 01
- Healthy Transitions in Late Stage Kidney Disease Start of enrollment: 2013 Oct 01
- Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis Start of enrollment: 2014 Jun 26
- Join now to see all
Publications & Presentations
PubMed
- Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.Pagliaro, L., Zhao, S., Edelstein, S., Spiegel, D., Rosenbaum, D., Sprague, S., Weiner, D., Tietjen, D., Pergola, P., Fishbane, S., Block, G., Silva, A., Fadem, S., Ly...> ;Kidney360. 2024 Feb 7
- 1 citationsHypoxia-inducible factor stabilizers: 27 228 patients studied, yet a role still undefined.Steven Fishbane, Deepa A Malieckal, Ji H Ng> ;Clinical Kidney Journal. 2023 May 1
- 5 citationsErythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.Mark J Koury, Rajiv Agarwal, Glenn M Chertow, Kai-Uwe Eckardt, Steven Fishbane, Tomas Ganz, Volker H Haase, Mark R Hanudel, Patrick S Parfrey, Pablo E Pergola, Prabir ...> ;American Journal of Hematology. 2022 Sep 1
- Join now to see all
Journal Articles
- Administrative Leadership: Nephrologists in Non-Nephrology Leadership RolesMichael Gitman, Alessandro Bellucci, Steven Fishbane, Advances in Chronic Kidney Disease
Lectures
- A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with PruritusAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/10/2019
- Intravenous Epoetin Alfa-Epbx Versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney DiseaseAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
Authored Content
- A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with PruritusJanuary 2020
Press Mentions
- Northwell Announces $1.25M Endowed, First-of-Its-Kind Kidney FellowshipJuly 20th, 2022
- Common Gene Variant May Predict Peritoneal Dialysis OutcomesOctober 20th, 2021
- FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual MeetingDecember 2nd, 2020
- Join now to see all
Hospital Affiliations
- Long Island Jewish Medical CenterNew Hyde Park, New York
- North Shore University HospitalManhasset, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: